Clinical Characteristics of Mycoplasma pneumoniae Pneumonia in Children and Risk Factors for Progression to Severe Disease.

Authors

Chao Fu, Xiang He, Chengcheng Li, Shirong Luo, Yunrong Li

Published in

Canadian respiratory journal. Volume 2026. Issue 1. Pages e5938199.

Abstract

To understand the clinical characteristics of severe and nonsevere Mycoplasma pneumoniae pneumonia (MPP) in children and analyze the risk factors for severe Mycoplasma pneumoniae pneumonia (SMPP), providing a basis for early clinical diagnosis and treatment of SMPP.
A retrospective analysis was conducted on 146 children with MPP admitted to pediatric wards 1-4 of Zunyi First People's Hospital from August 2024 to June 2025. According to the severity of their condition, the patients were divided into a severe group (n = 49) and a nonsevere group (n = 97). Clinical manifestations, imaging data, and laboratory indicators were compared between the two groups, and logistic regression analysis was used to summarize the risk factors for pediatric SMPP.
(1) The duration of fever and cough was significantly longer in the severe MPP group than in the nonsevere group (p < 0.05). Compared with those in the nonsevere group, instances of prematurity, intrauterine infection at birth, pulmonary consolidation, pleural effusion, high fever, wheezing, and difficulty breathing were significantly more frequent in the severe group (p < 0.05). (2) Laboratory indicators, such as C-reactive protein levels, lactate dehydrogenase levels, D-dimer levels, ferritin levels, the neutrophil ratio, and serum amyloid A levels, were significantly greater in the severe group than in the nonsevere group (p < 0.05). (3) The risk factors for SMPP included prematurity (OR = 4.747; 95% CI: 1.259 ∼ 17.891; p = 0.021), pulmonary consolidation (OR = 5.277; 95% CI: 1.372 ∼ 20.301; p = 0.016), high fever (OR = 25.597; 95% CI: 6.760 ∼ 96.926; p < 0.001), wheezing (OR = 6.913; 95% CI: 1.837 ∼ 26.017; p = 0.004), and difficulty breathing (OR = 5.990; 95% CI: 1.451 ∼ 24.722; p = 0.013).
Children with SMPP have prolonged fever and cough, more severe clinical symptoms, and significantly elevated inflammation-related laboratory indicators. Prematurity, pulmonary consolidation, high fever, wheezing, and difficulty breathing are easily accessible baseline warning indicators for early identification of children at high risk of progression to SMPP. Strengthening early recognition and timely intervention in patients presenting with these factors may help optimize clinical management and improve outcomes.

PMID:
42745613
Bibliographic data and abstract were imported from PubMed on 16 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.